Craig A. Erickson MD

Child & Adolescent Psychiatry

Professor, Cincinnati Children’s Hospital, University of Cincinnati College of Medicine

Education & Training

Indiana University School of Medicine (Indianapolis)Residency, Psychiatry, 2004 - 2007
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2003 - 2004
University of Cincinnati College of MedicineClass of 2003

Riluzole in Fragile X Syndrome Start of enrollment: 2009 Apr 01
Completed
Phase 4
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders Start of enrollment: 2010 Mar 01
Completed
Phase 3
Acamprosate in Youth With Fragile X Syndrome Start of enrollment: 2010 Aug 01
Completed
Phase 2
Study of Acamprosate in Autism Start of enrollment: 2013 Jul 02
Completed
Phase 1
Study of Acamprosate in Fragile x Syndrome Start of enrollment: 2013 Aug 27
Completed
Phase 1
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD Start of enrollment: 2022 Jun 23
Terminated
Phase 2
Roles: Principal Investigator, Contact
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age Start of enrollment: 2022 Oct 04
RECRUITING
NA
Roles: Contact
Study of SPG601 in Adult Men With Fragile X Syndrome Start of enrollment: 2024 Jul 05
COMPLETED
PHASE2
Roles: Contact, Principal Investigator
Join now to see all

PubMed

Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder.
Craig A Erickson, Rebecca C Shaffer, Meredith Will, Lauren M Schmitt, Paul Horn
Journal of Autism and Developmental Disorders. 2025-09-01
Hyper-extralemniscal model of Fragile X syndrome.
Makoto Miyakoshi, Hyeonseok Kim, Lisa A De Stefano, Lauren M Schmitt, Jordan E Norris
Cerebral Cortex. 2025-06-04
1 citations
Health Related Quality of Life in Autistic Youth and Their Families.
Meredith A Nelson, Rebecca C Shaffer, Lauren M Schmitt, Marika C Coffman, Paul S Horn
Journal of Autism and Developmental Disorders. 2025-06-01

Journal Articles

Author Correction: Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible
Ernest Pedapati, Craig A Erickson, Nature
Full Length Article Pharmacological Management of Behavioral Disturbances in Children and Adolescents with Autism Spectrum Disorders
Craig A. Erickson, Martine Lamy, ScienceDirect
Impaired Perceptual Learning in a Mouse Model of Fragile X Syndrome Is Mediated by Parvalbumin Neuron Dysfunction and Is Reversible
Ernest Pedapati, Craig A Erickson, Nature

European Medicines Agency Grants Orphan Drug Designation to Spinogenix's SPG601 for Treatment of Fragile X Syndrome (FXS)July 7th, 2025
Going on Trial: Serotonin Drug; Psilocybin Phase 2; Placebo Response DataApril 28th, 2023
Finding a Path Forward for Fragile X DrugsSeptember 23rd, 2021
Join now to see all